Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
N Engl J Med. 2024 Jun 2. doi: 10.1056/NEJMoa2402604. Online ahead of print.
N Engl J Med. 2024.
PMID: 38828984
Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials.
Versluis JM, Menzies AM, Sikorska K, Rozeman EA, Saw RPM, van Houdt WJ, Eriksson H, Klop WMC, Ch'ng S, van Thienen JV, Mallo H, Gonzalez M, Torres Acosta A, Grijpink-Ongering LG, van der Wal A, Bruining A, van de Wiel BA, Scolyer RA, Haanen JBAG, Schumacher TN, van Akkooi ACJ, Long GV, Blank CU.
Versluis JM, et al. Among authors: torres acosta a.
Ann Oncol. 2023 Apr;34(4):420-430. doi: 10.1016/j.annonc.2023.01.004. Epub 2023 Jan 18.
Ann Oncol. 2023.
PMID: 36681299
Free article.
Clinical Trial.
Item in Clipboard
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
Rohaan MW, Borch TH, van den Berg JH, Met Ö, Kessels R, Geukes Foppen MH, Stoltenborg Granhøj J, Nuijen B, Nijenhuis C, Jedema I, van Zon M, Scheij S, Beijnen JH, Hansen M, Voermans C, Noringriis IM, Monberg TJ, Holmstroem RB, Wever LDV, van Dijk M, Grijpink-Ongering LG, Valkenet LHM, Torres Acosta A, Karger M, Borgers JSW, Ten Ham RMT, Retèl VP, van Harten WH, Lalezari F, van Tinteren H, van der Veldt AAM, Hospers GAP, Stevense-den Boer MAM, Suijkerbuijk KPM, Aarts MJB, Piersma D, van den Eertwegh AJM, de Groot JB, Vreugdenhil G, Kapiteijn E, Boers-Sonderen MJ, Fiets WE, van den Berkmortel FWPJ, Ellebaek E, Hölmich LR, van Akkooi ACJ, van Houdt WJ, Wouters MWJM, van Thienen JV, Blank CU, Meerveld-Eggink A, Klobuch S, Wilgenhof S, Schumacher TN, Donia M, Svane IM, Haanen JBAG.
Rohaan MW, et al. Among authors: torres acosta a.
N Engl J Med. 2022 Dec 8;387(23):2113-2125. doi: 10.1056/NEJMoa2210233.
N Engl J Med. 2022.
PMID: 36477031
Clinical Trial.
Item in Clipboard
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial.
Reijers ILM, Menzies AM, van Akkooi ACJ, Versluis JM, van den Heuvel NMJ, Saw RPM, Pennington TE, Kapiteijn E, van der Veldt AAM, Suijkerbuijk KPM, Hospers GAP, Rozeman EA, Klop WMC, van Houdt WJ, Sikorska K, van der Hage JA, Grünhagen DJ, Wouters MW, Witkamp AJ, Zuur CL, Lijnsvelt JM, Torres Acosta A, Grijpink-Ongering LG, Gonzalez M, Jóźwiak K, Bierman C, Shannon KF, Ch'ng S, Colebatch AJ, Spillane AJ, Haanen JBAG, Rawson RV, van de Wiel BA, van de Poll-Franse LV, Scolyer RA, Boekhout AH, Long GV, Blank CU.
Reijers ILM, et al. Among authors: torres acosta a.
Nat Med. 2022 Jun;28(6):1178-1188. doi: 10.1038/s41591-022-01851-x. Epub 2022 Jun 5.
Nat Med. 2022.
PMID: 35661157
Clinical Trial.
Item in Clipboard
Reinforced Concrete Structure Performance in Marine Structures: Analyzing Durability Indexes to Obtain More Accurate Corrosion Initiation Time Predictions.
Arreola-Sanchez M, Alonso-Guzman EM, Martinez-Molina W, Torres-Acosta AA, Chavez-Garcia HL, Ponce-Ortega JM.
Arreola-Sanchez M, et al. Among authors: torres acosta aa.
Materials (Basel). 2021 Dec 12;14(24):7662. doi: 10.3390/ma14247662.
Materials (Basel). 2021.
PMID: 34947256
Free PMC article.
Item in Clipboard
Durability Performance Indices for Cement-Based Mortars.
Visairo-Méndez R, Torres-Acosta AA, Alvarado-Cárdenas R.
Visairo-Méndez R, et al. Among authors: torres acosta aa.
Materials (Basel). 2021 May 23;14(11):2758. doi: 10.3390/ma14112758.
Materials (Basel). 2021.
PMID: 34071023
Free PMC article.
Item in Clipboard
Opuntia Ficus-Indica (OFI) Mucilage as Corrosion Inhibitor of Steel in CO2-Contaminated Mortar.
Torres-Acosta AA, González-Calderón PY.
Torres-Acosta AA, et al.
Materials (Basel). 2021 Mar 9;14(5):1316. doi: 10.3390/ma14051316.
Materials (Basel). 2021.
PMID: 33803426
Free PMC article.
Item in Clipboard
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.
Rozeman EA, Hoefsmit EP, Reijers ILM, Saw RPM, Versluis JM, Krijgsman O, Dimitriadis P, Sikorska K, van de Wiel BA, Eriksson H, Gonzalez M, Torres Acosta A, Grijpink-Ongering LG, Shannon K, Haanen JBAG, Stretch J, Ch'ng S, Nieweg OE, Mallo HA, Adriaansz S, Kerkhoven RM, Cornelissen S, Broeks A, Klop WMC, Zuur CL, van Houdt WJ, Peeper DS, Spillane AJ, van Akkooi ACJ, Scolyer RA, Schumacher TNM, Menzies AM, Long GV, Blank CU.
Rozeman EA, et al. Among authors: torres acosta a.
Nat Med. 2021 Feb;27(2):256-263. doi: 10.1038/s41591-020-01211-7. Epub 2021 Feb 8.
Nat Med. 2021.
PMID: 33558721
Clinical Trial.
Item in Clipboard
Cite
Cite